Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by
widespread intravascular activation of coagulation that can be caused by infectious insults …

Cancer patients have an increased risk of venous thromboembolism (VTE). In this review,
we summarize common and cancer type–specific pathways of VTE in cancer patients …

Disseminated intravascular coagulation (DIC) is a condition characterized by systemic
activation of coagulation, potentially leading to thrombotic obstruction of small and midsize …

One-quarter to one-third of ischemic strokes have no established mechanism after standard
diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS) …

The close relationship between cancer and thrombosis is known since more than a century.
Venous thromboembolism (VTE) may be the first manifestation of an occult malignancy in an …

Coagulopathy is a severe and frequent complication in critically ill patients, for which the
pathogenesis and presentation may be variable depending on the underlying disease …

Gastric cancer (GC) is the most common gastrointestinal malignant tumor, and distant
metastasis is a critical factor in the prognosis of patients with GC. Understanding the …

Blood perfusion in tumors can be significantly lower than that in the surrounding normal
tissue owing to the leakiness and/or compression of tumor blood vessels. Impaired perfusion …

In the past decade, the therapeutic value of mesenchymal stromal cells (MSCs) has been
studied in various indications, thereby taking advantage of their immunosuppressive …